LINDSAY WAGNER: Open Payments
NPI 1285815209 · CONCORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,658 in 75 payments from 19 companies in 2025. Trend: 2023 $1,143 · 2024 $1,474 · 2025 $1,658
Food & beverage: $1,658
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $272 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $235 |
| PFIZER INC. | 9 | $140 |
| Esperion Therapeutics, Inc. | 5 | $128 |
| Lilly USA, LLC | 9 | $125 |
| AstraZeneca Pharmaceuticals LP | 5 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $103 |
| Novo Nordisk Inc | 5 | $95 |
| Amgen Inc. | 4 | $83 |
| CVRx, Inc. | 2 | $61 |
Products named: LEQVIO, LifeVest, NEXLETOL, MOUNJARO, Kerendia, VYNDAQEL, Repatha, WAINUA.
Industry payments across CA — which companies pay providers there.
